Market Closed -
Other stock markets
|
Pre-market 08:35:17 | |||
40.49 USD | -1.82% | 40.35 | -0.35% |
01:41pm | Bristol-Myers Squibb Gains EU Approval for Opdivo Combination Therapy for Urothelial Cancer | MT |
01:26pm | Bristol Myers: new EC approval for Opdivo | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.09% | 82.08B | |
+38.59% | 727B | |
+30.54% | 592B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.29% | 238B | |
+6.99% | 204B | |
-5.56% | 203B | |
-1.70% | 160B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol-Myers Squibb Agrees to Acquire Turning Point Therapeutics for $4.1 Billion